SUN PHARMA Fact Sheet, SUN PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Fact Sheet    (SUNP)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of SUN PHARMA. For more details, see the SUN PHARMA quarterly results and SUN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 807.0
Mkt Cap Rs m 1,936,263
Vol '000 325.4
P/E X 30.9
P/CF X 44.4
EPS (TTM) Rs 26.1
1 Day % 0.9
No. of shares m 2,399.34
1 Week % -5.4
1 Month % 2.8
1 Year % 37.6
52 week H/L Rs 871.0/550.7
As on Jan 25, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs842701679484654 
Low Rs572433375315339 
Sales per share (Unadj.) Rs129.4109.8121.1136.9139.6 
Earnings per share (Unadj.) Rs32.710.713.417.49.5 
Diluted earnings per shareRs32.710.713.417.49.5 
Cash flow per share (Unadj.) Rs37.917.020.726.018.2 
Dividends per share (Unadj.) Rs3.502.002.754.007.50 
Adj. dividends per shareRs3.502.002.754.007.50 
Avg Dividend yield %0.50.40.51.01.5 
Book value per share (Unadj.) Rs152.7159.7172.6188.7193.6 
Adj. book value per shareRs152.7159.7172.6188.7193.6 
Shares outstanding (eoy) m2,399.262,399.322,399.342,399.342,399.34 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x5.55.24.42.93.6 
Avg P/E ratio x21.753.039.422.952.1 
P/CF ratio (eoy) x18.633.425.515.427.3 
Price / Book Value ratio x4.63.53.12.12.6 
Dividend payout %10.718.720.622.978.8 
Avg Mkt Cap Rs m1,696,8771,360,0561,264,689958,8941,190,430 
No. of employees `000NANANANANA 
Total wages/salary Rs m49,02353,67159,67163,62468,622 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SUN PHARMA INCOME DATA
Net Sales Rs m310,378263,416290,659328,375334,981 
Other income Rs m10,3029,12110,5946,5168,592 
Total revenues Rs m320,680272,537301,253334,891343,573 
Gross profit Rs m96,82245,84350,59367,13541,616 
Depreciation Rs m12,64814,99817,53320,52820,800 
Interest Rs m3,9985,1765,5533,0271,414 
Profit before tax Rs m90,47934,79038,10250,09627,994 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m12,1169,1106,0098,2285,147 
Profit after tax Rs m78,36325,67932,09341,86822,847 
Gross profit margin %31.217.417.420.412.4 
Effective tax rate %13.426.215.816.418.4 
Net profit margin %25.29.711.012.86.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m329,537316,359310,692316,542304,421 
Current liabilities Rs m178,870198,643173,396157,064161,456 
Net working cap to sales %48.544.747.248.642.7 
Current ratio x1.81.61.82.01.9 
Inventory Days Days67184148158149 
Debtors Days Days8510811210599 
Net fixed assets Rs m259,638304,731310,698334,230336,682 
Share capital Rs m2,3992,3992,3992,3992,399 
"Free" reserves Rs m363,971380,742411,691450,245462,229 
Net worth Rs m366,370383,141414,091452,645464,628 
Long term debt Rs m14,36117,72115,22620,2898,981 
Total assets Rs m589,174621,090621,389650,772641,103 
Interest coverage x23.67.77.917.520.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.40.50.50.5 
Return on assets %14.05.06.16.93.8 
Return on equity %21.46.77.89.24.9 
Return on capital %24.810.010.211.26.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m44,11851,40366,02574,21984,493 
Fx outflow Rs m24,48432,23338,61027,96430,334 
Net fx Rs m19,63419,17027,41546,25554,159 
SUN PHARMA CASH FLOW
From Operations Rs m 70,822 39,072 21,965 65,548 61,704 
From Investments Rs m -42,216 -33,708 -6,813 -25,888 5,362 
From Financial Activity Rs m -22,854 -15,393 -27,305 -57,151 -59,805 
Net Cashflow Rs m 6,107 -7,359 -8,442 -13,857 5,964 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 54.5%
Institution 34.0%
Non-Institution 11.5%
Total 100.0%
Free Float 45.5%
Pledged promoter holdings 4.8%
Shareholding as on Dec 2021
 

Company Information

Regd Off Sun Pharma Advanced Research Centre (S P A R C), Tandalja, Vadodara - 390020
E-mail secretarial@sunpharma.com Web www.sunpharma.com
Tel 0265- 5515500 / 5515600 / 5515700 Fax 0265- 2354897
Sector PHARMACEUTICALS Group Sun Pharmaceutical Group
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
Auditor Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.9

Read: SUN PHARMA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    

Compare SUN PHARMA With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    




Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS